The International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society grading system has limited prognostic significance in advanced resected pulmonary adenocarcinoma
Authors:
- Christopher W. ToonCTChristopher W. Toon
- Anthony J. GillAGAnthony J. Gill
- 1 October 2013
- Vol. 45 (6) , 553-558
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Paradigm shifts in lung cancer as defined in the new IASLC/ATS/ERS lung adenocarcinoma classificationEuropean Respiratory Journal, 2011
- Targeting Anaplastic Lymphoma Kinase in Lung CancerClinical Cancer Research, 2011
- International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung AdenocarcinomaJournal of Thoracic Oncology, 2011
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung CancerNew England Journal of Medicine, 2010
- Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFRNew England Journal of Medicine, 2010
- Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trialThe Lancet Oncology, 2010
- Gefitinib or Carboplatin–Paclitaxel in Pulmonary AdenocarcinomaNew England Journal of Medicine, 2009
- Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2008
- Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation studyNature Medicine, 2008
- Staging classification of lung cancer: A Critical EvaluationClinics in Chest Medicine, 2002